Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$459M |
| 2 |
Tesla
TSLA
|
+$216M |
| 3 |
WBS
Webster Financial
WBS
|
+$202M |
| 4 |
Warner Bros
WBD
|
+$198M |
| 5 |
Teck Resources
TECK
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$821M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$220M |
| 3 |
NVIDIA
NVDA
|
+$211M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$201M |
| 5 |
CYBR
CyberArk
CYBR
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.79% |
| 2 | Financials | 4.4% |
| 3 | Consumer Discretionary | 3.69% |
| 4 | Industrials | 3.64% |
| 5 | Healthcare | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
CALL
Royal Gold
RGLD
$22.7B
| $662K | ﹤0.01% |
2,600
-1,700
| -40% | -$451K |
|
2627
CALL
MP Materials
MP
$10.7B
| $661K | ﹤0.01% |
13,700
-5,800
| -30% | -$347K |
|
2628
Immatics
IMTX
$1.26B
| $660K | ﹤0.01% |
67,048
+12,328
| +23% | +$121K |
|
2629
PUT
Halozyme
HALO
$12.4B
| $659K | ﹤0.01% |
10,200
+7,000
| +219% | +$493K |
|
2630
Vir Biotechnology
VIR
$1.81B
| $659K | ﹤0.01% |
73,504
+4,930
| +7% | +$39.3K |
|
2631
PUT
Norwegian Cruise Line
NCLH
$7.93B
| $658K | ﹤0.01% |
35,200
-2,400
| -6% | -$52.4K |
|
2632
CALL
SELLAS Life Sciences
SLS
$2.85B
| $658K | ﹤0.01% |
155,600
-530,100
| -77% | -$2.37M |
|
2633
PUT
VF Corp
VFC
$5.44B
| $656K | ﹤0.01% |
+38,600
| New | +$728K |
|
2634
PUT
Moody's
MCO
$88.9B
| $654K | ﹤0.01% |
+1,500
| New | +$710K |
|
2635
CALL
Protagonist Therapeutics
PTGX
$9.74B
| $653K | ﹤0.01% |
6,200
+2,700
| +77% | +$239K |
|
2636
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.45B
| $647K | ﹤0.01% |
+13,044
| New | +$657K |
|
2637
CALL
Bitdeer Technologies
BTDR
$3.07B
| $647K | ﹤0.01% |
74,800
+64,500
| +626% | +$678K |
|
2638
CALL
Elevance Health
ELV
$86.5B
| $644K | ﹤0.01% |
2,200
-23,200
| -91% | -$7.62M |
|
2639
PUT
MasTec
MTZ
$19.8B
| $643K | ﹤0.01% |
+2,000
| New | +$541K |
|
2640
Taysha Gene Therapies
TSHA
$2.02B
| $642K | ﹤0.01% |
+143,575
| New | +$668K |
|
2641
PUT
Gold Fields
GFI
$43.7B
| $640K | ﹤0.01% |
14,100
-32,400
| -70% | -$1.63M |
|
|
SCHW
2642
CALL
Charles Schwab
SCHW
$194B
| $639K | ﹤0.01% |
6,800
-8,500
| -56% | -$834K |
|
2643
Patrick Industries
PATK
$2.74B
| $638K | ﹤0.01% |
+5,745
| New | +$710K |
|
2644
PUT
IAMGOLD
IAG
$12.7B
| $638K | ﹤0.01% |
33,900
-800
| -2% | -$15.9K |
|
2645
CALL
Samsara
IOT
$22.8B
| $637K | ﹤0.01% |
20,100
-99,900
| -83% | -$3.05M |
|
|
KMTS
2646
Kestra Medical Technologies
KMTS
$1.58B
| $636K | ﹤0.01% |
+31,900
| New | +$752K |
|
2647
CALL
GSK
GSK
$104B
| $635K | ﹤0.01% |
11,500
-13,400
| -54% | -$726K |
|
2648
PUT
Vaalco Energy
EGY
$602M
| $634K | ﹤0.01% |
+100,000
| New | +$504K |
|
2649
PUT
MGM Resorts International
MGM
$10.9B
| $633K | ﹤0.01% |
+17,100
| New | +$609K |
|
2650
Douglas Emmett
DEI
$2.04B
| $631K | ﹤0.01% |
67,038
-702,453
| -91% | -$7.23M |
|
Similar funds
Paul Tudor Jones's Q1 2026 Portfolio in Review
As of Q1 2026, Paul Tudor Jones held 4,438 positions worth $53.9B, down 0.3% from $54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Paul Tudor Jones deployed $2B of net new capital in Q1 2026, opening 1,030 new positions and adding to 1,219 existing holdings. Its largest new stake was Warner Bros: 7,055,087 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 5.8% of assets, down from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $821M trimmed.
- Paul Tudor Jones's largest Q1 2026 buy was Warner Bros: 7,055,087 shares worth $194M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $459M increase.
- Paul Tudor Jones's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $821M.
- Paul Tudor Jones fully exited Exact Sciences in Q1 2026, selling an estimated $201M.
- Paul Tudor Jones's ten largest holdings make up 29% of its $53.9B portfolio in Q1 2026.
- Paul Tudor Jones opened 1,030 new positions and closed 924 in Q1 2026.
- Paul Tudor Jones's portfolio value fell 0.3% quarter-over-quarter to $53.9B.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.